The DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index.
Iron and cancer: recent insights
Open accessAbstract
Iron is an essential dietary element. However, the ability of iron to cycle between oxidized and reduced forms also renders it capable of contributing to free radical formation, which can have deleterious effects, including promutagenic effects that can potentiate tumor formation. Dysregulation of iron metabolism can increase cancer risk and promote tumor growth. Cancer cells exhibit an enhanced dependence on iron relative to their normal counterparts, a phenomenon we have termed iron addiction. Work conducted in the past few years has revealed new cellular processes and mechanisms that deepen our understanding of the link between iron and cancer. Control of iron efflux through the combined action of ferroportin, an iron efflux pump, and its regulator hepcidin appears to play an important role in tumorigenesis. Ferroptosis is a form of iron‐dependent cell death involving the production of reactive oxygen species. Specific mechanisms involved in ferroptosis, including depletion of glutathione and inhibition of glutathione peroxidase 4, have been uncovered. Ferritinophagy is a newly identified mechanism for degradation of the iron storage protein ferritin. Perturbations of mechanisms that control transcripts encoding proteins that regulate iron have been observed in cancer cells, including differences in miRNA, methylation, and acetylation. These new insights may ultimately provide new therapeutic opportunities for treating cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cancer cells have a high demand for easily accessible labile Fe2+ for their survival and growth.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,032
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Flagged first, then by citations
1 of the 121 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1371/journal.pgen.1003408 · DOI
Cited by
Sorted by citations
Items 401–500 of 515
Cui, K., Tang, S., Wei, J., Wang, W.-P., & Deng, Y. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102046 · Cited by 1
“The proliferation of cancer cells is overly dependent on iron, as opposed to normal cells [17].”
Qiu, P.-H., Lin, C., Peng, Y.-P., Chen, K., Chen, Y., Lin, Y., & Lai, C.-H. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104826 · Cited by 1
Zeng, X., Jiang, L., Li, H., Wang, J., & He, X. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00942-4 · Cited by 1
Chitambar, C. R., Zoss, C. J., Al-Gizawiy, M. M., Schmainda, K. M., & Connelly, J. M. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100138 · Cited by 2
Lactylation at the crossroads: Bridging metabolic rewiring and ferroptotic vulnerability in cancer
Liu, Y., Yang, Q., Wang, X., & Hai, Z. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104341 · Cited by 1
“Iron is an obligatory cofactor for ribo-nucleotide reductase, the rate-limiting enzyme in dNTP synthesis, and for the mitochondrial electron transport chain complexes [13].”
Szukalska, M., Frączyk, T., Florek, E., & Pączek, L. (2023) · Molecules · doi:10.3390/molecules28020628 · Cited by 1
“Disruption of Fe metabolism increases the risk of carcinogenesis [67].”
BackgroundImpacts of iron on ultrastructural features of NCI-H295R cell line related to steroidogenesis
Ďúranová, H., Fialková, V., Šimora, V., Bilčíková, J., Massányi, P., Lukáč, N., & Kňažická, Z. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152056 · Cited by 1
Idowu, O. P., Oketayo, O. O., Oluwadare, O. J., Igboama, W. N., Olaniyan, D. S., Ezekiel, L., Ignatius, C., Isaac, M., Danbaki, A., Olasele, A., et al. (2024) · World Journal of Public Health · doi:10.11648/j.wjph.20240902.18 · Cited by 1
Metabolism of Essential Trace Elements and Associated Disorders
Ubaid, S., & Pandey, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_9 · Cited by 2
Ferritin-to-Transferrin Ratio: A New Prognostic Factor for Renal Cell Carcinoma
Xie, H., Huang, Y., He, H., Chen, R., Li, Y., Lu, H., & Yi, X. (2025) · Urologia Internationalis · doi:10.1159/000543589 · Cited by 1
Tada, Y., Hojo, M., Yuzawa, K., Nagasawa, A., Suzuki, J., Inomata, A., Moriyasu, T., & Nakae, D. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105072 · Cited by 1
Zaichick, V. (2022) · Journal of Biotechnology & Bioinformatics Research · doi:10.47363/jbbr/2022(4)144 · Cited by 1
“Fe metabolism is therefore very carefully regulated at both a systemic and cellular level [77,78].”
Is Artesunate the Best Partner of Gemcitabine in Pancreatic Cancer?
Koltai, T. (2022) · European Journal of Clinical Medicine · doi:10.24018/clinicmed.2022.3.3.202 · Cited by 1
“This would explain apoptosis in the malignant cells with minor adverse events in normal cells, because while the intracellular content of iron is high in tumors [35], [36], it is significantly”
BackgroundWang, W., Chang, G., Zhuo, R., & Ye, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.949457 · Cited by 1
“Compared with normal cells, malignant cells excessively depend on iron for cell proliferation, that is, iron addiction (Manz et al., 2016).”
BackgroundNovia, N., Rosdiana, N., & Supriatmo (2022) · Bali Medical Journal · doi:10.15562/bmj.v11i3.3595 · Cited by 1
Chen, J., Hu, C., Pan, R., Du, X., Fu, H., & Shan, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-45663/v1 · Cited by 1
Amereh, M., Seyfoori, A., Shojaei, S., Lane, S., Zhao, T., Barough, M. S., Lum, J. J., Walter, P. B., & Akbari, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.01.582997 · Cited by 1
“It is known as an important part of prosthetic groups of proteins such as heme, iron-sulfur, cytochrome P450 and cytochromes, which are required for oxidative phosphorylation and detoxification processes [9].”
BackgroundMultiple Modes of Hepcidin Regulation in Breast Cancer
Farra, N. (2017) · OpenCommons - UConn (University of Connecticut)
Novel non-apoptotic cell death: ferroptosis
Woo, S. M., & Kwon, T. K. (2017) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2017.34.2.174
Caspases and Cancer: Connections through Circular Dichroism Spectroscopy
Hethcox, S. M. (2019)
Controversial Impact of Hepcidin Metabolism in the Pathogenesis of Anemia in Myelofibrosis
Dimitrova, S., Gercheva, L., Gerova, D. I., & Micheva, I. (2020) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20200804.13
“Although ferritin maintained an adverse predictive value for overall survival independently of anemia, RBC transfusions and the toxic effect of iron overload, it was supposed to sequesters excess iron, allowing iron to accumulate intracellularly while preventing iron-mediated free radical-generating reactions [5].”
BackgroundZhu, Z., Cao, H., Huang, H., Zhan, H., Liu, Z., Lu, K., Zhang, T., Miao, C., & Wu, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-264542/v1
Iron Metabolism: From Inflammation to Cancer
Paola, A. D., Tortora, C., Argenziano, M., Leva, C. D., & Rossi, F. (2021) · Annals of Hematology & Oncology · doi:10.26420/annhematoloncol.2021.1351
“Proteins involved in regulation of iron metabolism show an alteration of their expression and activity in cancer cells [24], for example, TFR-1 is present at very high levels in several solid tumors [102, 106-108] and in leukemia [105].”
BackgroundInfluentialRole of glutathione in ferroptosis of tumor cells
Yang, F., Tan, N., Zhang, T., & Cheng, T. (2021) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v29.i15.901
Ferroptosis assassinates tumor (FAST)Preprint
Luo, T., Wang, Y., & Wang, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.463002
Cai, J., Gu, J., Ge, D., & Xu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-1022283/v1
Leitao, R. C. F. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.75.2021.tde-24012022-095506
Zhu, Z., Huang, C., Sun, A., Zhan, H., Liu, Z., Lu, K., Zhang, T., Miao, C., & Wu, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-264542/v2
Controversial Impact of Hepcidin Metabolism in the Pathogenesis of Anemia in Myelofibrosis
Dimitrova, S., Gercheva, L., Gerova, D. I., & Micheva, I. (2019) · Advanced Biomedicine · doi:10.54730/abm.2019.010505
Guo, Y., Song, C., Zhang, L., Han, Z., & Zhu, L. (2022) · Research Square · doi:10.21203/rs.3.rs-2317277/v1
Nutrition and Diet: A Double-Edged Sword in Development and Treatment of Brain Tumors
Sadeghmousavi, S., Rezaei, N., & Hanaei, S. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-14732-6_10
Li, C., Gao, N., & hua, Y. R. (2023) · Research Square · doi:10.21203/rs.3.rs-2683039/v1
Atiya, H. I., Frisbie, L. G., Goldfeld, E., Orellana, T. J., Donnellan, N. M., Modugno, F., Calderon, M. J., Watkins, S. C., Zhang, R., Elishaev, E., et al. (2023) · doi:10.1158/0008-5472.c.6514212.v1
Atiya, H. I., Frisbie, L. G., Goldfeld, E., Orellana, T. J., Donnellan, N. M., Modugno, F., Calderon, M. J., Watkins, S. C., Zhang, R., Elishaev, E., et al. (2023) · doi:10.1158/0008-5472.c.6514212
Molecular Regulation Mechanisms of Ferroptosis and Its Progress in AML Treatment
Wang, R., Zhou, Z., Chen, N., Li, Z., & Li, H. (2023) · Transactions on Cancer · doi:10.23977/tranc.2023.040109
“Relative to normal cells, tumor cells indeed show stronger dependence on iron in the environment[9-10].”
BackgroundFeatures of regulation of hepcidin and ferroportin in cancer patients (literary review)
Blindar, V. N., Зубрихина, Г. Н., Давыдова, Т. В., & Dobrovolskaya, M. M. (2023) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2023-22-3-10-18
Identification and Verification of Potential Ferroptosis-Related Biomarkers in Cervical Cancer
Liu, Z., Liu, Y., Wu, X., Feng, X., & Liang, W. P. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2024.3810
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14906074
Hong, Y., Zhang, L., Tian, X., Xiang, X., Yu, Y., Zeng, Z., Cao, Y., Chen, S., & Sun, A. (2021) · Figshare · doi:10.6084/m9.figshare.17204932
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14906065
Hong, Y., Zhang, L., Tian, X., Xiang, X., Yu, Y., Zeng, Z., Cao, Y., Chen, S., & Sun, A. (2021) · Figshare · doi:10.6084/m9.figshare.17204926
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14906071
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14906068
Interaction of Tapentadol with Selected Metal Ions Studied by UV-Vis and FTIR Spectroscopy
Salsabil, S., Alam, S., Salam, A., Sharif, J., & Sultan, Z. (2024) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/1305/1/012006
“Disruptions in the control of these vital metals during typical biochemical reactions are linked to the emergence of numerous pathological conditions, for example, deficiency of certain ions for long term like iron, zinc, and copper can cause oncogenesis [2-3].”
BackgroundChitosan-modified hetero-aromatic β-ketosulfones for iron(III) sensing and biological applications
Al-Amshany, Z. M., Alamry, K. A., El‐Shishtawy, R. M., & Hussein, M. A. (2024) · Inorganic and Nano-Metal Chemistry · doi:10.1080/24701556.2024.2354924
“Detection of Fe 3 þ is therefore essential, given that its overabundance in the environment has been associated with numerous diseases, including Alzheimer’s, Parkinson’s syndrome, and malignancy [29, 30].”
Cancer stem cells—Challenges for cancer therapies
Arora, R., Uboveja, A., & Kadamb, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13209-4.00018-0
Mao, M., Zhuang, Y., & Yu, H. (2024) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2024.2433113
“Regulation of iron metabolism is a basic rule underlying nearly all existing life and feeds into the progression of cancer (Manz et al. 2016).”
Zhang, H., Wang, Y., Zhang, X., Shao, Y., & Hu, M. (2025) · Research Square · doi:10.21203/rs.3.rs-5987113/v1
Duensing, H. M., Dixon, J. M., Hunter, O. R., Graves, N. C., Smith, N. C., Tomes, A. J., & Fahrenholtz, C. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146628 · Cited by 1
“Artemisinins and derivatives induce rapid oxidative damage by virtue of the unique endoperoxide bridge and are known to be cytotoxic to a variety of cancer cells derived from an assortment of tissues [18,22–24].”
Effect of iron on the anticancer activity of in vitro photodynamic therapy using PhotolonTM
Lee, S., & Lee, J. I. (2025) · Medical Biological Science and Engineering · doi:10.30579/mbse.2025.8.2.65
Zhao, Y., Li, H., Liu, D., Feng, K., Wang, H., Liu, T.-W., Yang, L., Wang, J., & Hou, B.-F. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02216-2
“Cancer cells require more iron than normal cells, and imbalances in iron metabolism can increase the risk of cancer and promote tumor growth [19].”
Islam, G. U., Andleeb, S., Abbasi, W. A., Liaqat, I., Ali, N. M., & Nazir, A. (2025) · Water Environment Research · doi:10.1002/wer.70200
“Furthermore, excessive iron levels can elevate cancer risk and damage the nervous system and other vital organs (Badran et al. 2024; Fatima et al. 2025; Genchi et al. 2020; Manz et al. 2016; Salnikow 2021; B. Tiwari et al. 2024; Torti and Torti 2020).”
Hu, W., Zhou, C., Jing, Q., Li, Y., Yang, J., Yang, C., Wang, L., Hu, J., Li, H., Wang, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17704597
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826719
Hu, W., Zhou, C., Jing, Q., Li, Y., Yang, J., Yang, C., Wang, L., Hu, J., Li, H., Wang, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17704603
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826728
Hu, W., Zhou, C., Jing, Q., Li, Y., Yang, J., Yang, C., Wang, L., Hu, J., Li, H., Wang, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17704606
Tang, B., Zhu, J., Li, J., Fan, K., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161696
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826731
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558540
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558549
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558555
Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., Yang, C., Yuan, C., Li, H., Tong, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256983
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558531
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558558
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558543
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14906062
Hong, Y., Zhang, L., Tian, X., Xiang, X., Yu, Y., Zeng, Z., Cao, Y., Chen, S., & 孙爱宁 (2021) · Figshare · doi:10.6084/m9.figshare.17204923
Tang, B., Zhu, J., Li, J., Fan, K., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161702
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558537
Tang, B., Zhu, J., Li, J., Fan, K., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161693
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558561
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558564
Hu, W., Zhou, C., Jing, Q., Li, Y., Yang, J., Yang, C., Wang, L., Hu, J., Li, H., Wang, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17704600
Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., Yang, C., Yuan, C., Li, H., Tong, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256977
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826734
Wang, L., Zhao, S., Wang, Y., Liu, J., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.25649379
Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., Yang, C., Yuan, C., Li, H., Tong, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256980
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14906053
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826716
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826722
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558552
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · Figshare · doi:10.6084/m9.figshare.22826725
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558546
Tang, B., Zhu, J., Li, J., Fan, K., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161699
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14906059
Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., Yang, C., Yuan, C., Li, H., Tong, X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256974
Yao, J., Chen, X., Liu, X., Li, R., Zhou, X., & Qu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14906056
Tang, Y., Ge, S., Zheng, X., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26558534
Chen, J., Wang, Z., Fu, J., Cai, Y., Cheng, H., Cui, X., Sun, M., Liu, M., & Zhang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26711942
Shu, H., Sia, C. S., Tiang, S. S. L., Goh, B.-H., Low, Y. J., Tey, B. T., & Low, L. E. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108211
Targeted delivery and controlled release of deferasirox for melanoma therapy
Su, X., Zhao, W., Wang, L., Song, P., Wang, X., Jin, X., & Zhang, H. (2026) · iScience · doi:10.1016/j.isci.2026.115303
Ferroptosis as a novel targeted therapy in gynecological malignant tumors
Yu, C., Li, Y., Fu, Y., Yang, R., Nakevska, Z., Kumar, P. P., Tong, A. Y., Yang, N., Liu, D., Chen, C., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-04686-x
“Research has shown that cancer cells have a higher iron requirement for survival compared to normal cells [17].”
Rôle de l'autophagie dans l'émergence des cellules souches cancéreuses : implication du métabolisme
El-Hout, M. (2019) · theses.fr (ABES) · doi:10.70675/881cf980z01caz4a56z8a81zdcebe1247536
Metadata
- Authors
- Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V.
- Affiliations
- Department of Molecular Biology and Biophysics
- UConn Health (US)
- Corresponding author
- Torti, Suzy V.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2016-02-18
- Volume
- 1368
- Issue
- 1
- Pages
- 149-161
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- PMC
- PMC4870095
- OpenAlex
- W2275201610
- Cited by
- 507
- References
- 121
- Citations by year
- 2026: 24 · 2025: 49 · 2024: 69 · 2023: 78 · 2022: 66 · 2021: 77 · 2020: 46 · 2019: 43 · 2018: 31 · 2017: 14 · 2016: 10
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- S.V.T (CA188025)
- F.M.T (CA171101)
- D.H.M. (DE021989)
- U.S. National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron metabolism, cancer, ferroptosis, ferroportin, hepcidin, iron efflux, reactive oxygen species, glutathione depletion, GPX4, ferritinophagy, ferritin degradation, tumor microenvironment, epigenetic regulation, microRNA, DNA methylation, histone acetylation, cancer therapy
- MeSH terms
- Ferroportin, Animals, Humans, Iron, Neoplasms, Reactive Oxygen Species, Iron Overload, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review